Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Brief
On March 12, 2025, the Italian Medicines Agency (AIFA) initiated a public consultation on the document "Criteria for evaluation to attribute therapeutic innovativeness" and management of antibiotics for multi-resistant germ infections. The consultation is a preliminary step towards defining criteria for attributing therapeutic innovativeness by AIFA for access to the Innovative Medicine Fund, as per the Italian Law No. 207 of December 30, 2024.
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
